Cord Blood Transplant

The rope that was discarded shortly after the birth of a baby's blood is considered as a rescue device for future generations of a family. It has thus become imperative to safeguard the precious blood that is rich in cells instem necessary for the treatment of the lives of many serious diseases. In the past decade, several cord blood transplants have been performed worldwide as an alternative for the treatment of cancer and serious genetic disorders. Marrow First Blood was made in 1988

There are different sources of stem cells out of blood and the umbilical cord is one of three sources for obtaining hematopoietic cells used for transplantation. The other two sources are bone marrow and peripheral (circulating) blood. It is collected at the time of delivery after the birth of the baby. The cord blood is collected carefully by the hospital staff who are trained in the service. It is then tested, frozen and stored at the blood bank for future use ACORD. The stored blood is called a cord blood unit (CBU).

The National Marrow Donor Program (NMDP) Registry includes more than 70,000 CBU. Doctors search the NMDP Registry of adult bone marrow or peripheral blood donor cells and HSEC finding HLA compatible donor for their patients who need transplants. If selected, the corresponding blood is transfused to a patient. The transplant process is the same as for marrow cell transplants andperipheral blood

The use of cord blood transplants has increased for both children and adults. It is used most often in children as an umbilical cord contains a limited amount of blood. The number of hematopoietic cells in a transplant must match the size of the patient - most often in young patients require fewer cells and older patients need several elements. SSEC Some may not be sufficient for some patients hematopoietic cells.

Doctors are trying different ways to increase the number of cells in a CBU so they can use cord blood for larger patients. One method under consideration is to give patients the two units. Another method under consideration is to increase the number of cells in a laboratory before giving it to the patient.

When your doctor looks into the NMDP Registry, he or she will choose the best source of cells for you. Maybe marrow or peripheral blood of a donor adult or it may be a unit of CB. A doctor may choose cord blood because of some of how it differs from bone marrow orperipheral.

A close match between the patient and the donor or CBU can improve outcomes of patients after transplantation. Even if a close correspondence, it is always preferred, clinical studies suggest the game may not be as close as needed for blood marrow orperipheral. It may take two months or more to find a bone marrow or peripheral blood. A unit can be selected and delivered to the transplant center in less than two weeks. Your doctor may choose cord blood if you need a transplant soon.

But chances are that your doctor may not approve of transplanting cord blood. Possible reasons for this are:

* It may not be sufficient hematopoietic cells in a unit for the size of the patient.

* It usually takes over cord blood cells to engraft (begin to grow and create new blood cells and immune system). Until the transplanted cells, the patient is at high risk of infection.

* Patients can not obtain cells for the Protection of the CBU itself. If a patient transplanted marrow or peripheral blood cells do not transplant or relapse patients, the patient may be able to get a second gift of the donor was an adult. After transplantation, this option is not available. However, doctors may be able to use another unit or a backup adult donor instead.

Cord blood transplants also have the same risks as the bone marrow and peripheral blood transplants. The risk of infection may be higher after.